FIMI buys 50% of Pharm-Up

Pharm-Up provides medical logistics and services for pharmaceuticals, medical equipment, and clinical trials.

FIMI Opportunity Funds (FIMI) has signed an agreement to acquire 50% of Pharm-Up Ltd. at a valuation of NIS 170 million. FIMI founder and CEO Ishay Davidi said, "The investment in Pharm-Up is based on FIMI's confidence in its great potential and its area of business. Medical logistics and related services require expertise and excellence. FIMI, which in the past was a controlling partner in Orian and is currently a partner in Overseas Commerce, has the experience and know-how to offer a company in these fields."

Pharm-Up chairman Shaul Kobrinsky said, "FIMI's becoming an equal controlling partner is a vote of confidence in the company and its management, and greatly strengthens the ability to meet the growth and operating expansion challenges planned for the years ahead. We believe that teaming with the extensive experience and knowledge of FIMI's managers in improving companies will result in Pharm-Up's further growth and development."

Pharm-Up provides medical logistics and services for pharmaceuticals, medical equipment, and clinical trials. The company offers its clients a range of logistics and other services, including the import, storage, distribution, and collection from one of the world's most advanced computer facilities located at the Modiin Industrial Zone.

Published by Globes [online], Israel business news - www.globes-online.com - on September 8, 2013

© Copyright of Globes Publisher Itonut (1983) Ltd. 2013

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Twitter Facebook Linkedin RSS Newsletters גלובס MAD Conference 2017